Phospholipase D in cellular senescence.
Cellular senescence appears to be an important part of organismal aging. Cellular senescence is characterized by flattened enlarged morphology, inhibition of DNA replication in response to growth factors, inability to phosphorylate the pRb tumor suppressor protein, inability to produce c-fos or AP-1 and overexpression of a variety of genes, notably p21 (CIP-1/WAF-1) and p16(INK). It is now clear that certain early mitotic signals become defective with the onset of senescence. Among these is the PLD/PKC pathway. Evidence suggests that activation of PLD and PKC is critical for mitogenesis. Recent data suggest that the defect in PLD/PKC in cellular senescence is a result of elevated cellular ceramide levels which inhibit PLD activation. It appears that the elevated ceramide is a result of neutral sphingomyelinase activation. Ceramide acts to inhibit the activation of PLD by possibly three mechanisms, inhibiting activation by Rho, translocation to the membrane and gene expression. Addition of ceramide to young cells not only inhibits PLD but also recapitulates all the standard measures of cellular senescence as described above.
Venable
M E
ME
Biology Department, Appalachian State University, P.O. Box 32027, Boone, NC 28608-2027, USA. venableme@appstate.edu
Obeid
L M
LM
D000818:Animals; D016922:Cellular Senescence / Q000502:physiology*; D002518:Ceramides / Q000494:pharmacology / Q000502:physiology*; D015971:Gene Expression Regulation, Enzymologic / Q000187:drug effects; D006801:Humans; D008938:Mitosis; D010739:Phospholipase D / Q000037:antagonists & inhibitors / Q000235:genetics / Q000378:metabolism*; D015290:Second Messenger Systems; D013108:Sphingomyelin Phosphodiesterase / Q000378:metabolism; D016615:Telomere / Q000502:physiology
D002518:Ceramides; C101954:N-caproylsphingosine; D013108:Sphingomyelin Phosphodiesterase; D010739:Phospholipase D